Reiko Yanagihara
Review Director of Office of New Drug V in Pharmaceuticals & Medical Devices Agency (PMDA), Japan
Dr. Reiko Yanagihara is Review Director of Office of New Drug V in Pharmaceuticals & Medical Devices Agency (PMDA). She joined PMDA in 2009 and served in the area of biopharmaceuticals, biosimilars in vitro diagnostics and cancer drugs. She has been a member of companion diagnostics (CDx) working group in PMDA since 2014 which discusses regulatory issues and the development of relevant guidance on CDx.